| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |